Business Wire
04 Sept 2026, 14:49 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
1 claim · each scored for market impact
A class action lawsuit has been filed on behalf of investors who purchased Unicycive Therapeutics (UNCY) common stock between December 29, 2025, and June 29, 2026. — Securities litigation typically creates downward pressure on stock prices due to potential legal liabilities and perceived management failures.
-0.40Which stocks this story touches
The company is the subject of a class action lawsuit filed on behalf of investors who suffered losses.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
16h ago
